High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab

DSpace Repository

High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab

Author: Weber, Tobias; Boetticher, Benedikt; Mier, Walter; Sauter, Max; Kraemer, Susanne; Leotta, Karin; Keller, Armin; Schlegelmilch, Anne; Grosse-Hovest, Ludger; Jaeger, Dirk; Haberkorn, Uwe; Arndt, Michaela A. E.; Krauss, Juergen
Tübinger Autor(en):
Große-Hovest, Ludger
Published in: European Journal of Nuclear Medicine and Molecular Imaging (2016), Bd. 43, H. 3, S. 489-498
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00259-015-3175-6
ISSN: 1619-7089
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)